These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10586395)

  • 41. Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children.
    Tran A; Rey E; Pons G; Pariente-Khayat A; D'Athis P; Sallerin V; Dupont C
    Clin Pharmacol Ther; 2002 May; 71(5):359-67. PubMed ID: 12011821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism.
    Ieiri I; Kishimoto Y; Okochi H; Momiyama K; Morita T; Kitano M; Morisawa T; Fukushima Y; Nakagawa K; Hasegawa J; Otsubo K; Ishizaki T
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):485-92. PubMed ID: 11699613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions.
    Rizzo N; Padoin C; Palombo S; Scherrmann JM; Girre C
    Eur J Clin Pharmacol; 1996; 49(6):491-5. PubMed ID: 8706775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect on bioavailability of admixing the contents of lansoprazole capsules with selected soft foods.
    Chun AH; Erdman K; Zhang Y; Achari R; Cavanaugh JH
    Clin Ther; 2000 Feb; 22(2):231-6. PubMed ID: 10743982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.
    Saito M; Yasui-Furukori N; Uno T; Takahata T; Sugawara K; Munakata A; Tateishi T
    Br J Clin Pharmacol; 2005 Mar; 59(3):302-9. PubMed ID: 15752376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous and oral lansoprazole are equivalent in suppressing stimulated acid output in patient volunteers with erosive oesophagitis.
    Kovacs TO; Lee CQ; Chiu YL; Pilmer BL; Metz DC
    Aliment Pharmacol Ther; 2004 Oct; 20(8):883-9. PubMed ID: 15479360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of pharmacokinetic interaction between pantoprazole and diclofenac.
    Bliesath H; Huber R; Steinijans VW; Koch HJ; Wurst W; Mascher H
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S76-80. PubMed ID: 8793607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lansoprazole and omeprazole in the treatment of acid peptic disorders.
    Blum RA
    Am J Health Syst Pharm; 1996 Jun; 53(12):1401-15. PubMed ID: 8781686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19.
    Kim KA; Shon JH; Park JY; Yoon YR; Kim MJ; Yun DH; Kim MK; Cha IJ; Hyun MH; Shin JG
    Clin Pharmacol Ther; 2002 Jul; 72(1):90-9. PubMed ID: 12152007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects.
    Sakai T; Aoyama N; Kita T; Sakaeda T; Nishiguchi K; Nishitora Y; Hohda T; Sirasaka D; Tamura T; Tanigawara Y; Kasuga M; Okumura K
    Pharm Res; 2001 Jun; 18(6):721-7. PubMed ID: 11474773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
    Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W
    Digestion; 1995; 56(2):137-44. PubMed ID: 7750667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of omeprazole on the steady-state pharmacokinetics of voriconazole.
    Wood N; Tan K; Purkins L; Layton G; Hamlin J; Kleinermans D; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):56-61. PubMed ID: 14616415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status.
    Furuta T; Shirai N; Sugimoto M; Nakamura A; Okudaira K; Kajimura M; Hishida A
    Aliment Pharmacol Ther; 2005 Jul; 22(1):67-74. PubMed ID: 15963082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of clarithromycin and other macrolides on the sulfoxidation and 5-hydroxylation of lansoprazole in dogs.
    Masa K; Arimori K; Nakayama T; Miyamoto S; Fujii J; Nakano M
    Biol Pharm Bull; 1999 May; 22(5):504-9. PubMed ID: 10375172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lansoprazole enantiomer activates human liver microsomal CYP2C9 catalytic activity in a stereospecific and substrate-specific manner.
    Liu KH; Kim MJ; Jung WM; Kang W; Cha IJ; Shin JG
    Drug Metab Dispos; 2005 Feb; 33(2):209-13. PubMed ID: 15537834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of nefazodone on the single-dose pharmacokinetics of phenytoin in healthy male subjects.
    Marino MR; Langenbacher KM; Hammett JL; Nichola P; Uderman HD
    J Clin Psychopharmacol; 1997 Feb; 17(1):27-33. PubMed ID: 9004054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ; Jarvis B
    Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine.
    Miura M; Tada H; Yasui-Furukori N; Uno T; Sugawara K; Tateishi T; Suzuki T
    Br J Clin Pharmacol; 2005 Jul; 60(1):61-8. PubMed ID: 15963095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
    Takeda H; Hokari K; Asaka M
    J Clin Gastroenterol; 1995; 20 Suppl 1():S7-9. PubMed ID: 7673616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Initial and chronic gastric acid inhibition by lansoprazole and omeprazole in relation to meal administration.
    Brummer RJ; Geerling BJ; Stockbrügger RW
    Dig Dis Sci; 1997 Oct; 42(10):2132-7. PubMed ID: 9365148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.